Advance Search
HOU Baozhou, LI Huiping, WEI Sichen, MU Zongwei, LI Lijuan, TIAN Shuying. Clinical significance of serum vascular endothelial growth factor, soluble thymidine kinase-1 and T lymphocyte subsets in patients with primary hepatocellular carcinoma[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 98-102. DOI: 10.7619/jcmp.20214756
Citation: HOU Baozhou, LI Huiping, WEI Sichen, MU Zongwei, LI Lijuan, TIAN Shuying. Clinical significance of serum vascular endothelial growth factor, soluble thymidine kinase-1 and T lymphocyte subsets in patients with primary hepatocellular carcinoma[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 98-102. DOI: 10.7619/jcmp.20214756
shu

Clinical significance of serum vascular endothelial growth factor, soluble thymidine kinase-1 and T lymphocyte subsets in patients with primary hepatocellular carcinoma

  • 1.

    the Second Department of Gastroenterology,Cangzhou City Central Hospital in Hebei Province, Cangzhou, Hebei, 061000

  • 2.

    Section of Medical Affairs, Cangzhou City Central Hospital in Hebei Province, Cangzhou, Hebei, 061000

More Information
  • Received Date: December 02, 2021
  • Available Online: April 14, 2022
  • Published Date: April 14, 2022
    Graphical Abstract
    • Abstract
  •   Objective  To analyze the correlations of serum vascular endothelial growth factor (VEGF), soluble thymidine kinase-1 (TK-1) and T lymphocyte subsets with clinicopathological features of tumors and survival prognosis in patients with liver cancer.
      Methods  Clinical materials of 105 patients diagnosed as hepatocellular carcinoma from September 2018 to September 2020 were retrospectively analyzed, and serum VEGF, TK-1 and T lymphocyte subsets (percentages of CD3+, CD4+ and CD8+ and CD4+/CD8+) at hospital admission were detected.
      Results  VEGF and TK-1 at hospital admission were significantly correlated with hepatitis B virus (HBV) infection, TNM staging, differentiation level, lymph node metastasis, vascular infiltration and survival prognosis (P < 0.05). The CD4+/CD8+ at hospital admission was significantly correlated with HBV infection, TNM staging, differentiation level, lymph node metastasis, vascular infiltration and survival prognosis (P < 0.05). Compared with before treatment, the levels of VEGF and TK-1 decreased significantly, the percentage of CD4+ and CD4+/CD8+ increased significantly, and the percentage of CD8+ decreased significantly in 105 patients with liver cancer after treatment (P < 0.05). Multivariate Cox regression analysis showed that TNM staging (stage Ⅲto Ⅳ), lymph node metastasis, vascular infiltration, VEGF, TK-1 and CD4+/CD8+ were risk factors for survival prognosis (P < 0.05). The receiver operating characteristic (ROC) curve analysis showed that the values of area under the curve (AUC) of VEGF, TK-1 and CD4+/CD8+ in predicting survival prognosis were 0.824, 0.869 and 0.756, respectively, and the AUC of combined prediction was 0.912 (P < 0.05).
      Conclusion  The expressions of serum VEGF and TK-1 increase and CD4+/CD8+ decreases in patients with liver cancer, which are closely related to the clinicopathological features of tumors and the survival prognosis of patients. The combination of VEGF, TK-1 and CD4+/CD8+ has a high value in predicting the survival prognosis.
    • FullText(HTML)
    • References (24)
  • [1]
    MULLATH A, KRISHNA M. Hepatocellular carcinoma - time to take the ticket[J]. World J Gastrointest Surg, 2019, 11(6): 287-295. doi: 10.4240/wjgs.v11.i6.287
    [2]
    王铁忠, 王征, 袁嘉阳. 白细胞介素-6基因单核苷酸多态性与乙型肝炎患者肝癌易感性及临床预后的关系[J]. 中国基层医药, 2019, 26(14): 1670-1673. doi: 10.3760/cma.j.issn.1008-6706.2019.14.002
    [3]
    卢凌鹏, 黄艳芳. 血清中AFP, GPC3, DCP和VEGF 4种肿瘤标志物对原发性肝癌的早期诊断价值[J]. 实用癌症杂志, 2016, 31(9): 1399-1401. doi: 10.3969/j.issn.1001-5930.2016.09.003
    [4]
    刘海芳, 李早红. 血管内皮生长因子、基质金属蛋白酶2以及基质金属蛋白酶9对肝癌患者临床预后的影响分析[J]. 中国基层医药, 2020, 27(12): 1422-1426. doi: 10.3760/cma.j.issn.1008-6706.2020.12.004
    [5]
    李芳芳, 陶紫薇, 沈永利, 等. 基于血液DNA甲基化在肝癌诊断中的研究进展[J]. 实用临床医药杂志, 2021, 25(9): 117-122. doi: 10.7619/jcmp.20210641
    [6]
    WANG L Y, SHARIF H, SAELLSTRÖM S, et al. Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker[J]. BMC Vet Res, 2021, 17(1): 316. doi: 10.1186/s12917-021-03030-5
    [7]
    杨静文, 唐小童, 郭辉, 等. 免疫检查点HHLA2和PD-L1在肝癌组织中的表达及临床意义[J]. 蚌埠医学院学报, 2021, 46(4): 425-430. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG202104003.htm
    [8]
    鞠铭伊, 毕佳, 卫倩, 等. 肝癌免疫相关预后标志物的分析[J]. 郑州大学学报: 医学版, 2020, 55(6): 779-785. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYK202006010.htm
    [9]
    四川大学华西医院肝癌MDT团队, 严律南, 文天夫. 肝细胞肝癌全程多学科规范化管理: 华西医院多学科专家共识(第二版)[J]. 中国普外基础与临床杂志, 2020, 27(9): 1062-1072. https://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL202009005.htm
    [10]
    张庚, 王海伦, 梁东启, 等. 乏氧诱导因子-1和血管内皮生长因子在肝癌组织中的表达及其与肿瘤血管生成的相关性[J]. 中华实验外科杂志, 2021, 38(9): 1760-1760. doi: 10.3760/cma.j.cn421213-20210104-00021
    [11]
    宁建东, 彭怀斌, 张海峰. 原发性肝癌患者CT表现及其与VEGF及预后的关系[J]. 实用癌症杂志, 2021, 36(9): 1405-1409. doi: 10.3969/j.issn.1001-5930.2021.09.004
    [12]
    王计划, 谭文举. 血清AFP、CA19-9、VEGF用于预测中晚期肝癌TACE疗效的价值探讨[J]. 国际检验医学杂志, 2021, 42(17): 2067-2071. doi: 10.3969/j.issn.1673-4130.2021.17.005
    [13]
    LIU Z L, ZHU L L, LIU J H, et al. Vascular endothelial growth factor receptor-2 and its association with tumor immune regulatory gene expression in hepatocellular carcinoma[J]. Aging, 2020, 12(24): 25172-25188. doi: 10.18632/aging.104119
    [14]
    DAI C M, JIN S, ZHANG J Z. Effect of Dahuang Zhechong Pills combined with TACE on VEGF, MMP-2, TGF-β1 and immune function of patients with primary liver cancer (blood stasis and collaterals blocking type)[J]. China J Chin Mater Med, 2021, 46(3): 722-729.
    [15]
    MAO C S, YIN H, NING H B, et al. Levels of HBx, VEGF, and CEACAM1 in HBV-related hepatocellular carcinoma and their correlation with cancer prognosis[J]. Eur Rev Med Pharmacol Sci, 2017, 21(17): 3827-3833.
    [16]
    VIZIO B, BOSCO O, DAVID E, et al. Cooperative role of thrombopoietin and vascular endothelial growth factor-A in the progression of liver cirrhosis to hepatocellular carcinoma[J]. Int J Mol Sci, 2021, 22(4): 1818. doi: 10.3390/ijms22041818
    [17]
    谢荣章, 陈树华. 联合血清AFP、TK1及DKK1水平检测对原发性肝癌诊断价值研究[J]. 国际检验医学杂志, 2018, 39(8): 939-941, 946. doi: 10.3969/j.issn.1673-4130.2018.08.012
    [18]
    PAOLETTI C, BARLOW W E, COBAIN E F, et al. Evaluating serum thymidine kinase 1 in patients with hormone receptor-positive metastatic breast cancer receiving first-line endocrine therapy in the SWOG S0226 trial[J]. Clin Cancer Res, 2021, 27(22): 6115-6123. doi: 10.1158/1078-0432.CCR-21-1562
    [19]
    谢雯净, 梁猛. 血清TK1、AFP及CHI3L1预测放疗后原发性肝癌患者预后的临床价值[J]. 国际检验医学杂志, 2021, 42(12): 1495-1498. https://www.cnki.com.cn/Article/CJFDTOTAL-GWSQ202112021.htm
    [20]
    黄有全, 何雨, 黄天壬, 等. 乙型肝炎病毒原发性肝癌X区变异与外周血T淋巴细胞亚群的关系[J]. 广西医科大学学报, 2019, 36(10): 1576-1580. https://www.cnki.com.cn/Article/CJFDTOTAL-GXYD201910007.htm
    [21]
    赵阳. 紫草素对荷肝癌大鼠免疫功能的影响[J]. 西部中医药, 2018, 31(9): 26-29. https://www.cnki.com.cn/Article/CJFDTOTAL-GSZY201809007.htm
    [22]
    HUANG C Y, WANG Y, LUO G Y, et al. Relationship between PD-L1 expression and CD8+ T-cell immune responses in hepatocellular carcinoma[J]. J Immunother, 2017, 40(9): 323-333.
    [23]
    王碧玉, 王露莹, 羊文芳. 中晚期PHC患者TACE术前后血清Th1/Th2细胞因子AFP水平的变化及意义[J]. 河北医学, 2018, 24(6): 1028-1032. https://www.cnki.com.cn/Article/CJFDTOTAL-HCYX201806039.htm
    [24]
    贾蓓, 刘建宁, 张岁, 等. DC-CIK对肝癌患者免疫平衡的影响及临床疗效研究[J]. 河北医科大学学报, 2016, 37(4): 440-444. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYX201604017.htm
    • Related Articles

  • Related Articles

    [1]ZHOU Lina, HAN Yanhua, GENG Tiantian, LIU Li. Research progress in effects of hyperandrogenin and insulin resistance on placental pathology of polycystic ovary syndrome
    [J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 137-141. DOI: 10.7619/jcmp.20223478
    [2]WANG Yaning, CUI Liye, CHEN Yilin, JIA Hongchao. Correlations of serum interleukin-6, Janus kinase/signal transducers and activators of transcription protein with immune function in children with viral bronchiolitis[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 78-81. DOI: 10.7619/jcmp.20214423
    [3]XIE Yu, WANG Chun, JIANG Ming. Effects of different doses of Caltrate D supplementation on insulin resistance in patients with impaired glucose tolerance and vitamin D deficiency[J]. Journal of Clinical Medicine in Practice, 2017, (19): 59-62. DOI: 10.7619/jcmp.201719017
    [4]XU Zhengrong, LIU Ming, SUN Haifeng, HU Limei, ZUO Lijuan, ZHANG Qiuzi. Influencing factors and prevention of insulin resistance in first-degree relatives of Graves disease patients with abnormal glucose metabolism[J]. Journal of Clinical Medicine in Practice, 2015, (15): 41-43. DOI: 10.7619/jcmp.201515012
    [5]JIN Shilu, QU Dongdong. Changes of serum tumor necrosis factor-α and interlukin-6 levels in patients with non-alcoholic fatty liver and its correlation with insulin resistance[J]. Journal of Clinical Medicine in Practice, 2015, (5): 48-50. DOI: 10.7619/jcmp.201505015
    [6]YANG Zhiqin, ZHANG Xuehui, TANG Xinsheng. Effects of metformin on serum lipid metabolism and insulin resistance in patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2014, (23): 63-66. DOI: 10.7619/jcmp.201423021
    [7]BAI Xiaogang, LI Xia, LI Wei. Relationship between fasting serum resistin level and insulin resistance in the elderly type 2 diabetic patients with metabolic syndrome[J]. Journal of Clinical Medicine in Practice, 2014, (15): 4-7,24. DOI: 10.7619/jcmp.201415002
    [8]YANG Yongbi. Changes of serum adiponectin in hypertensive disorder complicating pregnancy patients with hypertension and its relationship with insulin resistance[J]. Journal of Clinical Medicine in Practice, 2014, (3): 124-126. DOI: 10.7619/jcmp.201403044
    [9]ZHU Dan. Comparison of effects of early intensive therapy and conventional therapy on β-cell function and insulin resistance in patients with preliminary diagnostic type 2 diabetes[J]. Journal of Clinical Medicine in Practice, 2013, (24): 10-12. DOI: 10.7619/jcmp.201324003
    [10]LI Caihui, JIA Xueqin. Study on the relationship between uric acid and insulin resistance in patients with gestational diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2013, (16): 113-114,119. DOI: 10.7619/jcmp.201316044

  • Cited by

    Periodical cited type(11)

    1. 刘盈，刘劲松，吴猛. 孕晚期经会阴超声联合血清弹性蛋白对产后盆底功能障碍的预测价值. 中国计划生育和妇产科. 2025(01): 78-83 .
    2. 周锋，李晓彦，岳丽，康华. 盆底超声参数联合血生化指标对产后早期压力性尿失禁的诊断效能. 中国超声医学杂志. 2025(03): 308-312 .
    3. 刘英，于水昌，杨红芳. 经会阴盆底超声联合血清sMFAP4、LTBP-2对产后盆底功能障碍性疾病的临床诊断价值. 检验医学与临床. 2025(06): 773-777 .
    4. 姜玉华，刘传金，王冰芝，王琳娜. 基于盆底超声参数及血清学指标建立的列线图模型预测初产妇压力性尿失禁的临床价值. 临床超声医学杂志. 2024(03): 244-248 .
    5. 张莹莹，梁琛，李晓燕，张艳玲，酒卫莉. 盆底功能障碍性疾病患者血清miR-4429和miR-19-3p水平表达及临床价值研究. 现代检验医学杂志. 2024(02): 119-123 .
    6. 杨博，石克威，李亚楠，尚芯羽. 初产妇产后血清25-（OH）D、OPN、TGF-β1水平对产后盆底功能障碍的预测价值. 分子诊断与治疗杂志. 2024(04): 725-729 .
    7. 张馨，安慧，蔡敏，张红菊. 生物电反馈刺激联合心理护理治疗对产后女性性功能障碍的作用. 空军军医大学学报. 2024(05): 563-566 .
    8. 郭倩倩，孟君艳，李斌. 盆底超声参数联合血清elafin、TGF-β1水平在预测产后压力性尿失禁中的应用价值. 国际泌尿系统杂志. 2024(06): 1083-1087 .
    9. 高鑫，贾红娥，李倩，康旺旺. 盆底三维超声参数联合血清基质金属蛋白酶-1、骨桥蛋白、结缔组织生长因子水平对压力性尿失禁疾病严重程度的预测价值. 陕西医学杂志. 2023(02): 149-153 .
    10. 林婕，白丽娟，沈秋妮，傅晓冬. 血清TIMP-1联合elafin水平对自然分娩初产妇产后压力性尿失禁的预测价值. 临床和实验医学杂志. 2023(15): 1628-1632 .
    11. 肖华，杨静，崔佑萍，杜欣. 针灸联合补中益气汤加减治疗产后盆底功能障碍的效果. 广西医学. 2022(16): 1885-1889 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (229) PDF downloads (14) Cited by(11)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return